#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4009141	B	Displacement of [3H]U-69,593 from kappa-type opioid receptor in guinea pig brain membranes after 120 mins by solid scintillation counting	Cavia porcellus	26		cell membrane format	Scientific Literature
2.	ALA4009142	B	Displacement of [3H]DAMGO from mu-type opioid receptor in guinea pig brain membranes after 120 mins by solid scintillation counting	Cavia porcellus	16		cell membrane format	Scientific Literature
3.	ALA4009144	B	Displacement of [3H]DPDPE from delta-type opioid receptor in guinea pig brain membranes after 120 mins by solid scintillation counting	Cavia porcellus	25		cell membrane format	Scientific Literature
4.	ALA4009146	B	Displacement of [3H]-(+)-pentazocine from sigma1-type opioid receptor in guinea pig cortex membranes at 1 uM after 120 mins by solid scintillation counting	Cavia porcellus	24		cell membrane format	Scientific Literature
5.	ALA4009148	B	Displacement of [3H]-DTG from sigma 2 receptor in rat liver membranes at 1 uM after 120 mins by scintillation counting	Rattus norvegicus	23		cell membrane format	Scientific Literature
6.	ALA4009150	B	Displacement of [3H]-(+)-MK 801 from PCP binding site of NMDA receptor in pig brain cortex membranes at 10 uM after 120 mins by solid scintillation counting	Sus scrofa	23		cell membrane format	Scientific Literature
7.	ALA4009152	F	Agonist activity at recombinant human kappa-type opioid receptor expressed in HEK293 cells after 30 mins by [35S]GTPgammaS binding assay	Homo sapiens	25		cell-based format	Scientific Literature
8.	ALA4009153	F	Agonist activity at recombinant human kappa-type opioid receptor expressed in HEK293 cells at 1 uM after 30 mins by [35S]GTPgammaS binding assay	Homo sapiens	25		cell-based format	Scientific Literature
9.	ALA4009187	F	Antiinflammatory activity in arachidonic acid-induced ear dermatitis ICR mouse model assessed as reduction in ear swelling at 0.1 mg administered twice tropically 30 mins prior and 15 mins after arachidonic acid addition measured 60 mins post arachidonic acid challenge relative to control	Mus musculus	14		assay format	Scientific Literature
10.	ALA4009188	F	Antiinflammatory activity in arachidonic acid-induced ear dermatitis ICR mouse model assessed as reduction in ear swelling at 0.3 mg administered twice tropically 30 mins prior and 15 mins after arachidonic acid addition measured 60 mins post arachidonic acid challenge relative to control	Mus musculus	13		assay format	Scientific Literature
11.	ALA4009189	F	Antiinflammatory activity in arachidonic acid-induced ear dermatitis ICR mouse model assessed as reduction in ear swelling at 1 mg administered twice tropically 30 mins prior and 15 mins after arachidonic acid addition measured 60 mins post arachidonic acid challenge relative to control	Mus musculus	13		assay format	Scientific Literature
12.	ALA4009190	F	Antiinflammatory activity in arachidonic acid-induced ear dermatitis ICR mouse model assessed as reduction in ear swelling at 3 mg administered twice tropically 30 mins prior and 15 mins after arachidonic acid addition measured 60 mins post arachidonic acid challenge relative to control	Mus musculus	14		assay format	Scientific Literature
13.	ALA4009203	F	Antiinflammatory activity in tropically administered oxazolone-induced delayed type hypersensitivity BALB/c mouse model assessed as effect on ear weight administered 3 hrs prior to oxazolone challenge on day 7 to 12 post sensitization followed by re-administration of compound on day 13 to 18 without oxazolone challenge measured on day 19	Mus musculus	4		assay format	Scientific Literature
14.	ALA4009220	F	Antiinflammatory activity in oxazolone-induced delayed type hypersensitivity BALB/c mouse model assessed as reduction in ear weight at 0.1 to 2.5 mg applied topically on ear administered 3 hrs prior to oxazolone challenge on day 7 to 12 post sensitization followed by re-administration of compound on day 13 to 18 without oxazolone challenge measured on day 19	Mus musculus	5		assay format	Scientific Literature
15.	ALA4009222	F	Antiinflammatory activity in oxazolone-induced delayed type hypersensitivity BALB/c mouse model assessed as effect on histology changes at 0.1 to 2.5 mg applied topically on ear administered 3 hrs prior to oxazolone challenge on day 7 to 12 post sensitization followed by re-administration of compound on day 13 to 18 without oxazolone challenge measured daily prior to treatment from day 7 to 19 by H and E staining based assay	Mus musculus	5		assay format	Scientific Literature